TD Cowen Reaffirms Their Buy Rating on Zoetis (ZTS)
TD Cowen's Steve Scala reaffirmed a Buy rating on Zoetis with a $150 price target. Scala, a 5-star analyst, has a 10.7% average return and a 63.78% success rate. Zoetis also received a Buy rating from Bank of America Securities, while KeyBanc initiated coverage with a Hold rating.
In a report released today, Steve Scala from TD Cowen maintained a Buy rating on Zoetis, with a price target of $150.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Scala is a 5-star analyst with an average return of 10.7% and a 63.78% success rate. Scala covers the Healthcare sector, focusing on stocks such as Pfizer, Eli Lilly & Co, and Novartis.
In addition to TD Cowen, Zoetis also received a Buy from Bank of America Securities’s Michael Ryskin in a report issued today. However, on November 20, KeyBanc initiated coverage with a Hold rating on Zoetis (NYSE: ZTS).
